lorazepam and 3-(2-carboxypiperazine-4-yl)propyl-1-phosphate

lorazepam has been researched along with 3-(2-carboxypiperazine-4-yl)propyl-1-phosphate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Greenblatt, DJ; Koff, JM; Miller, LG; Pritchard, GA	1

Other Studies

1 other study(ies) available for lorazepam and 3-(2-carboxypiperazine-4-yl)propyl-1-phosphate

Article	Year
The NMDA receptor competitive antagonist CPP modulates benzodiazepine tolerance and discontinuation. Pharmacology, 1997, Volume: 55, Issue:5 Topics: Animals; Cerebral Cortex; Drug Interactions; Drug Tolerance; Excitatory Amino Acid Antagonists; Hippocampus; Lorazepam; Male; Mice; Motor Activity; Pentylenetetrazole; Piperazines; Receptors, GABA-A; Receptors, N-Methyl-D-Aspartate; Seizures; Substance Withdrawal Syndrome	1997

Article

Year

The NMDA receptor competitive antagonist CPP modulates benzodiazepine tolerance and discontinuation.

Pharmacology, 1997, Volume: 55, Issue:5

Topics: Animals; Cerebral Cortex; Drug Interactions; Drug Tolerance; Excitatory Amino Acid Antagonists; Hippocampus; Lorazepam; Male; Mice; Motor Activity; Pentylenetetrazole; Piperazines; Receptors, GABA-A; Receptors, N-Methyl-D-Aspartate; Seizures; Substance Withdrawal Syndrome

1997